Basel, Switzerland

Main Schmidlin


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Main Schmidlin: Innovator in Pharmaceutical Systems

Introduction

Main Schmidlin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that enhances the interaction between pharmaceutical products and medical devices.

Latest Patents

Main Schmidlin holds a patent for a "System for use of a pharmaceutical product." This system comprises a container that accommodates a pharmaceutical product. The container is equipped with a wireless communication unit and a memory that stores pairing-specific information for one or more medical devices. Additionally, a medical device is enabled for wireless communication with the container's communication unit and is configured to read the pairing-specific information from the memory to verify whether the container is permitted to be used by the medical device. This innovation aims to improve the safety and efficacy of pharmaceutical applications.

Career Highlights

Main Schmidlin is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing advanced pharmaceutical systems that integrate technology with healthcare solutions. His contributions have been instrumental in enhancing patient care through innovative product designs.

Collaborations

Main Schmidlin has collaborated with notable colleagues, including Mario Iobbi and Erich Studer. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical technologies.

Conclusion

Main Schmidlin's work exemplifies the intersection of technology and healthcare, showcasing how innovative systems can enhance the use of pharmaceutical products. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…